awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38265934-35121455-828E-418C-BA37-C00E46AF0D1A
Q38265934-35121455-828E-418C-BA37-C00E46AF0D1A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38265934-35121455-828E-418C-BA37-C00E46AF0D1A
A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis.
P2860
Q38265934-35121455-828E-418C-BA37-C00E46AF0D1A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38265934-35121455-828E-418C-BA37-C00E46AF0D1A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4851dece77cb81635881aa5a729ea5eb65da46b1
P2860
Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis.